Результати пошуку - Silvia Geraci

  • Показ 1 - 4 результатів із 4
Уточнити результати
  1. 1
    Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis

    Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis за авторством Paul Harmatz, Federica Cattaneo, Diego Ardigò, Silvia Geraci, Julia B. Hennermann, Nathalie Guffon, Allan M. Lund, Christian J. Hendriksz, Line Borgwardt

    Опубліковано 2018
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

    Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD за авторством Dave Singh, Kai Michael Beeh, Brendan Colgan, Oliver Kornmann, Brian Leaker, Henrik Watz, Germano Lucci, Silvia Geraci, Aida Emirova, Mirco Govoni, Marie Anna Nandeuil

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Efficacy and safety of Velmanase alfa in the treatment of patients with alpha‐mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double‐blind, randomised, placebo‐controlled trial

    Efficacy and safety of Velmanase alfa in the treatment of patients with alpha‐mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double‐bl... за авторством Line Borgwardt, Nathalie Guffon, Yasmina Amraoui, Christine í Dali, Linda De Meırleır, Mercedes Gil‐Campos, Bénédicte Héron, Silvia Geraci, Diego Ardigò, Federica Cattaneo, J. Fogh, J. M. Hannerieke Van den Hout, Michael Beck, Simon Jones, Anna Tylki‐Szymańska, Ulla Haugsted, Allan M. Lund

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Comprehensive long‐term efficacy and safety of recombinant human alpha‐mannosidase (velmanase alfa) treatment in patients with alpha‐mannosidosis

    Comprehensive long‐term efficacy and safety of recombinant human alpha‐mannosidase (velmanase alfa) treatment in patients with alpha‐mannosidosis за авторством Allan M. Lund, Line Borgwardt, Federica Cattaneo, Diego Ardigò, Silvia Geraci, Mercedes Gil‐Campos, Linda De Meırleır, Cécile Laroche, Philippe Dolhem, Duncan Cole, Anna Tylki‐Szymańska, M. López Rodríguez, Encarna Guillén‐Navarro, Christine í Dali, Bénédicte Héron, J. Fogh, Nicole Muschol, Dawn Phillips, J. M. Hannerieke Van den Hout, Simon Jones, Yasmina Amraoui, Paul Harmatz, Nathalie Guffon

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: